88237

Culture/Harvest, Cytogenetics, Therapeutic Amniotic Fluid

CPT code 88237 describes the specific laboratory procedure for culturing and subsequently harvesting cells derived from therapeutic amniotic fluid samples for cytogenetic analysis. This intricate process is a foundational step in prenatal diagnosis, enabling the detection of various chromosomal abnormalities in the developing fetus. The amniotic fluid, typically obtained via amniocentesis (usually performed between 15 and 20 weeks of gestation), contains fetal cells known as amniocytes. These cells are unique in their ability to proliferate in vitro, making them suitable for genetic testing. Upon receipt in the cytogenetics laboratory, the amniotic fluid sample undergoes initial processing, which typically involves centrifugation to concentrate and pellet the fetal cells. These isolated amniocytes are then carefully resuspended in specialized, sterile culture media that provide the necessary nutrients and growth factors for cell division. The cell cultures are maintained in a controlled environment, usually a 37°C incubator with a regulated CO2 atmosphere, to encourage optimal growth and mitosis. The culturing period can range from 7 to 14 days, depending on cell viability and proliferation rates, to ensure a sufficient quantity of actively dividing cells for analysis. Once adequate cell growth is achieved, the cultures are 'harvested.' This critical step involves the addition of a mitotic inhibitor, such as colcemid or colchicine, which arrests the cells in metaphase – the stage where chromosomes are maximally condensed and visible. Following mitotic arrest, the cells are treated with a hypotonic solution to induce swelling and facilitate chromosome spreading. They are then fixed using a methanol:acetic acid solution to preserve their structural integrity. Finally, the fixed cell suspensions are meticulously dropped onto microscopic slides and air-dried, preparing them for subsequent staining (e.g., G-banding) and microscopic examination. The entire sequence, from the initial culture setup to the preparation of slides ready for analysis, is encompassed by CPT 88237. The term 'therapeutic' in this context refers to the diagnostic nature of the procedure, which provides information crucial for medical decision-making and patient management, rather than a direct intervention or treatment via the amniotic fluid itself.

Clinical Indications

  • Advanced maternal age (typically 35 years or older at the time of expected delivery) due to increased risk of aneuploidies.
  • Abnormal maternal serum screening results indicating an elevated risk for chromosomal abnormalities.
  • Fetal structural abnormalities or soft markers detected during prenatal ultrasound examinations.
  • Family history of a known chromosomal disorder or a genetic condition amenable to prenatal diagnosis.
  • Previous pregnancy or child with a chromosomal abnormality.
  • Parental carrier of a balanced chromosomal rearrangement (e.g., translocation, inversion) identified through genetic testing.
  • Detection of hydrops fetalis or other unexplained fetal anomalies.
  • Confirmation of high-risk results from non-invasive prenatal testing (NIPT).
  • Maternal anxiety regarding fetal health in the presence of other risk factors for chromosomal disorders.

Procedure Steps

  1. Sample Receipt and Accessioning: Amniotic fluid sample is received, verified for integrity and volume, and accessioned with a unique laboratory identifier.
  2. Centrifugation and Cell Isolation: The fluid is centrifuged to concentrate and pellet the fetal amniocytes.
  3. Culture Initiation: The pelleted cells are resuspended in sterile, complete culture medium and transferred to appropriate culture vessels (e.g., flasks, dishes).
  4. Incubation: Cultures are placed in a humidified incubator at 37°C with 5% CO2 to promote cell growth and proliferation.
  5. Culture Monitoring: Periodically observe cultures microscopically to assess cell growth, confluence, and identify any contamination.
  6. Harvesting - Mitotic Arrest: Once adequate cell growth is achieved (typically 7-14 days), a mitotic inhibitor (e.g., colcemid) is added to arrest cells in metaphase.
  7. Hypotonic Treatment: Cells are treated with a hypotonic solution (e.g., KCl) to swell the cells and spread chromosomes.
  8. Fixation: Cells are fixed in multiple changes of methanol:acetic acid solution to preserve cellular and chromosomal morphology.
  9. Slide Preparation: Fixed cell suspensions are dropped onto clean, chilled microscopic slides and air-dried to create metaphase spreads suitable for analysis.
  10. Quality Control of Slides: Slides are checked for optimal cell density, chromosome spreading, and clarity to ensure suitability for subsequent banding and analysis (which are reported separately).

Coding Guidelines

  • CPT code 88237 specifically covers the technical component of initiating and maintaining cell cultures and subsequently harvesting the cells for cytogenetic analysis from a therapeutic amniotic fluid specimen.
  • This code is typically reported once per amniotic fluid specimen, regardless of the number of culture vessels or aliquots used from that single specimen.
  • Code 88237 does NOT include the subsequent microscopic analysis, interpretation, or report generation of the chromosomes. These services are reported separately using codes such as 88264 (Karyotype, analysis), 88280 (Chromosomal analysis; additional counts), 88285 (Chromosomal analysis; additional cells), or 88289 (Chromosomal analysis; additional high resolution studies).
  • The term 'therapeutic' in the code description refers to the diagnostic nature of the test that informs patient management and treatment decisions, not a direct treatment within the amniotic fluid.
  • Medical necessity must be clearly documented in the patient's medical record to support the performance of this cytogenetic study (e.g., advanced maternal age, abnormal screening results, abnormal ultrasound findings, family history).
  • This code should not be used for culture and harvest of other specimen types (e.g., chorionic villi, peripheral blood, solid tissue), which have their own specific CPT codes (e.g., 88230, 88233, 88235).

Associated ICD-10 Codes